Personalized medicine is set to transform the diagnosis and treatment of many of the most prominent and dangerous diseases. By analyzing a patient or population’s genome, transcriptome or proteome, complete patient profiling is possible. For the engineer the key issue is to process the biomolecules so that they can be read into an electronic transducer. From then modern computing methods are sufficient to process and analyze the data. Microfluidics will be the key technology in overcoming the present bottleneck, providing a high throughput, low cost method to presenting molecular data to the transducer.
- Nanotechnology Institute
Microfluidics and Personalised Medicine
- Views Icon Views
- Share Icon Share
- Search Site
Davies, M, & Dalton, T. "Microfluidics and Personalised Medicine." Proceedings of the ASME 4th International Conference on Nanochannels, Microchannels, and Minichannels. ASME 4th International Conference on Nanochannels, Microchannels, and Minichannels, Parts A and B. Limerick, Ireland. June 19–21, 2006. pp. 1221-1226. ASME. https://doi.org/10.1115/ICNMM2006-96015
Download citation file: